APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Growth Hormone Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Growth Hormone Drugs Industry Growth and Trends Forecast to 2032

Report ID 173999750119 December 202596 pages

Choose your research edition.

Industry ResearchHuman Growth Hormone Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Growth Hormone Drugs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Human Growth Hormone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Growth Hormone Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Growth Hormone Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Human Growth Hormone Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Growth Hormone Drugs include Novo Nordisk A/S (Denmark), Merck KgaA (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Ferring Holding SA (Switzerland), Sandoz International GmbH (Germany), GeneScience Pharmaceuticals Co., Ltd. (China) and Genentech, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Growth Hormone Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Growth Hormone Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Growth Hormone Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Growth Hormone Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Growth Hormone Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Growth Hormone Drugs Market by Company

Novo Nordisk A/S (Denmark)

Merck KgaA (Germany)

Eli Lilly and Company (US)

Pfizer, Inc. (US)

Ferring Holding SA (Switzerland)

Sandoz International GmbH (Germany)

GeneScience Pharmaceuticals Co., Ltd. (China)

Genentech, Inc. (US)

Human Growth Hormone Drugs Segment by Type

Saizen

Genotropin

Humatrope

Norditropin

Omnitrope - the Somatropin Biosimilar

Somatropin Biopartners

Human Growth Hormone Drugs Segment by Application

Small for Gestational Age

Turner Syndrome

Prader-Willi Syndrome

Chronic Renal Insufficiency

Short Bowel Syndrome

Short Stature Homeobox Gene

Human Growth Hormone Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Growth Hormone Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Growth Hormone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Saizen Table 2. Major Company of Genotropin Table 3. Major Company of Humatrope Table 4. Major Company of Norditropin Table 5. Major Company of Omnitrope - the Somatropin Biosimilar Table 6. Major Company of Somatropin Biopartners Table 7. Global Human Growth Hormone Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 9. Global Human Growth Hormone Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Human Growth Hormone Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Human Growth Hormone Drugs Price by Type (2021-2026) & (US$/Unit) Table 13. Global Human Growth Hormone Drugs Sales by Type (2027-2032) & (K Units) Table 14. Global Human Growth Hormone Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Human Growth Hormone Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Human Growth Hormone Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Human Growth Hormone Drugs Price by Type (2027-2032) & (US$/Unit) Table 18. North America Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 19. North America Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 21. Europe Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 25. Latin America Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Human Growth Hormone Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Human Growth Hormone Drugs Industry Trends Table 29. Human Growth Hormone Drugs Industry Drivers Table 30. Human Growth Hormone Drugs Industry Opportunities and Challenges Table 31. Human Growth Hormone Drugs Industry Restraints Table 32. Global Human Growth Hormone Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Human Growth Hormone Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Human Growth Hormone Drugs Sales by Company (2021-2026) & (K Units) Table 35. Global Human Growth Hormone Drugs Sales Share by Company (2021-2026) Table 36. Global Human Growth Hormone Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Human Growth Hormone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Human Growth Hormone Drugs Major Company Production Sites and Headquarters Table 39. Global Human Growth Hormone Drugs Company, Product Type & Application Table 40. Global Human Growth Hormone Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Human Growth Hormone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Human Growth Hormone Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Human Growth Hormone Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Human Growth Hormone Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Human Growth Hormone Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Human Growth Hormone Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Human Growth Hormone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Human Growth Hormone Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global Human Growth Hormone Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Human Growth Hormone Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Human Growth Hormone Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Human Growth Hormone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Human Growth Hormone Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Human Growth Hormone Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Human Growth Hormone Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Human Growth Hormone Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Human Growth Hormone Drugs Sales by Application (2027-2032) & (K Units) Table 61. Global Human Growth Hormone Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Human Growth Hormone Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Human Growth Hormone Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Human Growth Hormone Drugs Price by Application (2027-2032) & (US$/Unit) Table 65. North America Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 66. North America Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 68. Europe Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 72. Latin America Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Human Growth Hormone Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Novo Nordisk A/S (Denmark) Company Information Table 76. Novo Nordisk A/S (Denmark) Business Overview Table 77. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio Table 79. Novo Nordisk A/S (Denmark) Recent Development Table 80. Merck KgaA (Germany) Company Information Table 81. Merck KgaA (Germany) Business Overview Table 82. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio Table 84. Merck KgaA (Germany) Recent Development Table 85. Eli Lilly and Company (US) Company Information Table 86. Eli Lilly and Company (US) Business Overview Table 87. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio Table 89. Eli Lilly and Company (US) Recent Development Table 90. Pfizer, Inc. (US) Company Information Table 91. Pfizer, Inc. (US) Business Overview Table 92. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio Table 94. Pfizer, Inc. (US) Recent Development Table 95. Ferring Holding SA (Switzerland) Company Information Table 96. Ferring Holding SA (Switzerland) Business Overview Table 97. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio Table 99. Ferring Holding SA (Switzerland) Recent Development Table 100. Sandoz International GmbH (Germany) Company Information Table 101. Sandoz International GmbH (Germany) Business Overview Table 102. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio Table 104. Sandoz International GmbH (Germany) Recent Development Table 105. GeneScience Pharmaceuticals Co., Ltd. (China) Company Information Table 106. GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview Table 107. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio Table 109. GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development Table 110. Genentech, Inc. (US) Company Information Table 111. Genentech, Inc. (US) Business Overview Table 112. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio Table 114. Genentech, Inc. (US) Recent Development Table 115. North America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. North America Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 117. North America Human Growth Hormone Drugs Sales Market Share by Country (2021-2026) Table 118. North America Human Growth Hormone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 119. North America Human Growth Hormone Drugs Sales Market Share Forecast by Country (2027-2032) Table 120. North America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Human Growth Hormone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Human Growth Hormone Drugs Market Share by Country (2021-2026) Table 123. North America Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Human Growth Hormone Drugs Market Share Forecast by Country (2027-2032) Table 125. Europe Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Europe Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 127. Europe Human Growth Hormone Drugs Sales Market Share by Country (2021-2026) Table 128. Europe Human Growth Hormone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 129. Europe Human Growth Hormone Drugs Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Human Growth Hormone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Human Growth Hormone Drugs Market Share by Country (2021-2026) Table 133. Europe Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Human Growth Hormone Drugs Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 137. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Human Growth Hormone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 139. Asia-Pacific Human Growth Hormone Drugs Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Human Growth Hormone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Human Growth Hormone Drugs Market Share by Country (2021-2026) Table 143. Asia-Pacific Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Human Growth Hormone Drugs Market Share Forecast by Country (2027-2032) Table 145. Latin America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Latin America Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 147. Latin America Human Growth Hormone Drugs Sales Market Share by Country (2021-2026) Table 148. Latin America Human Growth Hormone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 149. Latin America Human Growth Hormone Drugs Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Human Growth Hormone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Human Growth Hormone Drugs Market Share by Country (2021-2026) Table 153. Latin America Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Human Growth Hormone Drugs Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 157. Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Human Growth Hormone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 159. Middle East and Africa Human Growth Hormone Drugs Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Human Growth Hormone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Human Growth Hormone Drugs Market Share by Country (2021-2026) Table 163. Middle East and Africa Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Human Growth Hormone Drugs Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Human Growth Hormone Drugs Distributors List Table 168. Human Growth Hormone Drugs Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Human Growth Hormone Drugs Image Figure 2. Global Human Growth Hormone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Growth Hormone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Growth Hormone Drugs Sales (2021-2032) & (K Units) Figure 5. Saizen Image Figure 6. Global Saizen Sales YoY Growth (2021-2032) & (K Units) Figure 7. Genotropin Image Figure 8. Global Genotropin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Humatrope Image Figure 10. Global Humatrope Sales YoY Growth (2021-2032) & (K Units) Figure 11. Norditropin Image Figure 12. Global Norditropin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Omnitrope - the Somatropin Biosimilar Image Figure 14. Global Omnitrope - the Somatropin Biosimilar Sales YoY Growth (2021-2032) & (K Units) Figure 15. Somatropin Biopartners Image Figure 16. Global Somatropin Biopartners Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Human Growth Hormone Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Human Growth Hormone Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Human Growth Hormone Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Human Growth Hormone Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Human Growth Hormone Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Human Growth Hormone Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Human Growth Hormone Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Human Growth Hormone Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Human Growth Hormone Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Human Growth Hormone Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Human Growth Hormone Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Human Growth Hormone Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Human Growth Hormone Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Small for Gestational Age Image Figure 32. Global Small for Gestational Age Sales YoY Growth (2021-2032) & (K Units) Figure 33. Turner Syndrome Image Figure 34. Global Turner Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 35. Prader-Willi Syndrome Image Figure 36. Global Prader-Willi Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 37. Chronic Renal Insufficiency Image Figure 38. Global Chronic Renal Insufficiency Sales YoY Growth (2021-2032) & (K Units) Figure 39. Short Bowel Syndrome Image Figure 40. Global Short Bowel Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 41. Short Stature Homeobox Gene Image Figure 42. Global Short Stature Homeobox Gene Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Human Growth Hormone Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Human Growth Hormone Drugs Market Share by Application 2025 VS 2032 Figure 45. North America Human Growth Hormone Drugs Sales Market Share in Volume by Application in 2025 Figure 46. North America Human Growth Hormone Drugs Sales Market Share in Value by Application in 2025 Figure 47. Europe Human Growth Hormone Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Europe Human Growth Hormone Drugs Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Human Growth Hormone Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Human Growth Hormone Drugs Sales Market Share in Value by Application in 2025 Figure 51. Latin America Human Growth Hormone Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Human Growth Hormone Drugs Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Human Growth Hormone Drugs Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Human Growth Hormone Drugs Sales Market Share in Value by Application in 2025 Figure 55. North America Human Growth Hormone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Human Growth Hormone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Human Growth Hormone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Growth Hormone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Human Growth Hormone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Human Growth Hormone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Human Growth Hormone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Human Growth Hormone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Human Growth Hormone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Human Growth Hormone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Human Growth Hormone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Human Growth Hormone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Human Growth Hormone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Human Growth Hormone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Human Growth Hormone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Human Growth Hormone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Human Growth Hormone Drugs Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Human Growth Hormone Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Saizen
  • Genotropin
  • Humatrope
  • Norditropin
  • Omnitrope - the Somatropin Biosimilar
  • Somatropin Biopartners
Applications
  • Small for Gestational Age
  • Turner Syndrome
  • Prader-Willi Syndrome
  • Chronic Renal Insufficiency
  • Short Bowel Syndrome
  • Short Stature Homeobox Gene
Companies covered
  • Novo Nordisk A/S (Denmark)
  • Merck KgaA (Germany)
  • Eli Lilly and Company (US)
  • Pfizer, Inc. (US)
  • Ferring Holding SA (Switzerland)
  • Sandoz International GmbH (Germany)
  • GeneScience Pharmaceuticals Co., Ltd. (China)
  • Genentech, Inc. (US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Growth Hormone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Growth Hormone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Growth Hormone Drugs Market by Type
  6. 1.3.1 Saizen
  7. 1.3.2 Genotropin
  8. 1.3.3 Humatrope
  9. 1.3.4 Norditropin
  10. 1.3.5 Omnitrope - the Somatropin Biosimilar
  11. 1.3.6 Somatropin Biopartners
  12. 1.4 Global Human Growth Hormone Drugs Market Size by Type
  13. 1.4.1 Global Human Growth Hormone Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Human Growth Hormone Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Human Growth Hormone Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Human Growth Hormone Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Human Growth Hormone Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Human Growth Hormone Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Human Growth Hormone Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Human Growth Hormone Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Growth Hormone Drugs Industry Trends
  2. 2.2 Human Growth Hormone Drugs Industry Drivers
  3. 2.3 Human Growth Hormone Drugs Industry Opportunities and Challenges
  4. 2.4 Human Growth Hormone Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Growth Hormone Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Growth Hormone Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Human Growth Hormone Drugs Price (2021-2026)
  4. 3.4 Global Human Growth Hormone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Growth Hormone Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Human Growth Hormone Drugs Company, Product Type & Application
  7. 3.7 Global Human Growth Hormone Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Growth Hormone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Growth Hormone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Growth Hormone Drugs Tier 1, Tier 2, and Tier 3
4 Human Growth Hormone Drugs Regional Status and Outlook
  1. 4.1 Global Human Growth Hormone Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Growth Hormone Drugs Historic Market Size by Region
  3. 4.2.1 Global Human Growth Hormone Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Growth Hormone Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Growth Hormone Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Growth Hormone Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Human Growth Hormone Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Growth Hormone Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Growth Hormone Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Growth Hormone Drugs by Application
  1. 5.1 Human Growth Hormone Drugs Market by Application
  2. 5.1.1 Small for Gestational Age
  3. 5.1.2 Turner Syndrome
  4. 5.1.3 Prader-Willi Syndrome
  5. 5.1.4 Chronic Renal Insufficiency
  6. 5.1.5 Short Bowel Syndrome
  7. 5.1.6 Short Stature Homeobox Gene
  8. 5.2 Global Human Growth Hormone Drugs Market Size by Application
  9. 5.2.1 Global Human Growth Hormone Drugs Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Human Growth Hormone Drugs Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Human Growth Hormone Drugs Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Human Growth Hormone Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Human Growth Hormone Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Human Growth Hormone Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Human Growth Hormone Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Human Growth Hormone Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk A/S (Denmark)
  2. 6.1.1 Novo Nordisk A/S (Denmark) Company Information
  3. 6.1.2 Novo Nordisk A/S (Denmark) Business Overview
  4. 6.1.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio
  6. 6.1.5 Novo Nordisk A/S (Denmark) Recent Developments
  7. 6.2 Merck KgaA (Germany)
  8. 6.2.1 Merck KgaA (Germany) Company Information
  9. 6.2.2 Merck KgaA (Germany) Business Overview
  10. 6.2.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio
  12. 6.2.5 Merck KgaA (Germany) Recent Developments
  13. 6.3 Eli Lilly and Company (US)
  14. 6.3.1 Eli Lilly and Company (US) Company Information
  15. 6.3.2 Eli Lilly and Company (US) Business Overview
  16. 6.3.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio
  18. 6.3.5 Eli Lilly and Company (US) Recent Developments
  19. 6.4 Pfizer, Inc. (US)
  20. 6.4.1 Pfizer, Inc. (US) Company Information
  21. 6.4.2 Pfizer, Inc. (US) Business Overview
  22. 6.4.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio
  24. 6.4.5 Pfizer, Inc. (US) Recent Developments
  25. 6.5 Ferring Holding SA (Switzerland)
  26. 6.5.1 Ferring Holding SA (Switzerland) Company Information
  27. 6.5.2 Ferring Holding SA (Switzerland) Business Overview
  28. 6.5.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio
  30. 6.5.5 Ferring Holding SA (Switzerland) Recent Developments
  31. 6.6 Sandoz International GmbH (Germany)
  32. 6.6.1 Sandoz International GmbH (Germany) Company Information
  33. 6.6.2 Sandoz International GmbH (Germany) Business Overview
  34. 6.6.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio
  36. 6.6.5 Sandoz International GmbH (Germany) Recent Developments
  37. 6.7 GeneScience Pharmaceuticals Co., Ltd. (China)
  38. 6.7.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
  39. 6.7.2 GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview
  40. 6.7.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio
  42. 6.7.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
  43. 6.8 Genentech, Inc. (US)
  44. 6.8.1 Genentech, Inc. (US) Company Information
  45. 6.8.2 Genentech, Inc. (US) Business Overview
  46. 6.8.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio
  48. 6.8.5 Genentech, Inc. (US) Recent Developments
7 North America by Country
  1. 7.1 North America Human Growth Hormone Drugs Sales by Country
  2. 7.1.1 North America Human Growth Hormone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Growth Hormone Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Human Growth Hormone Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Growth Hormone Drugs Market Size by Country
  6. 7.2.1 North America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Growth Hormone Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Growth Hormone Drugs Sales by Country
  2. 8.1.1 Europe Human Growth Hormone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Growth Hormone Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Growth Hormone Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Growth Hormone Drugs Market Size by Country
  6. 8.2.1 Europe Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Growth Hormone Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Growth Hormone Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Human Growth Hormone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Growth Hormone Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Growth Hormone Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Growth Hormone Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Growth Hormone Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Growth Hormone Drugs Sales by Country
  2. 10.1.1 South America Human Growth Hormone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Growth Hormone Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Human Growth Hormone Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Growth Hormone Drugs Market Size by Country
  6. 10.2.1 South America Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Growth Hormone Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Growth Hormone Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Growth Hormone Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Human Growth Hormone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Growth Hormone Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Growth Hormone Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Growth Hormone Drugs Value Chain Analysis
  2. 12.1.1 Human Growth Hormone Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Growth Hormone Drugs Production Mode & Process
  7. 12.2 Human Growth Hormone Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Growth Hormone Drugs Distributors
  10. 12.2.3 Human Growth Hormone Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst